# 2024 ShieldYd Solutions |
ShieldYd addresses the challenge of off-target effects in antibody-based therapeutics, which can cause undesirable side effects in treatments for cancer and age-related diseases. This innovative approach includes antibody drugs designed to precisely target cancer and senescent cells, along with genetically encoded executioner proteins. By integrating advanced control mechanisms, ShieldYd enhances both safety and efficacy, minimising side effects while delivering potent treatments. This breakthrough represents a paradigm shift in antibody therapies, offering more reliable and precise treatment options to revolutionise patient care
Targeted antimicrobial treatment for resistant infections
Early detection and non-invasive correction of breech pregnancies